Guidelines by Topic

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (242)
Search within:  

Sort results by:      



Filter results by:

1-20 of 242   Next >
 
1.  
2.  
3.  
4.  
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120). 2000 Sep (revised 2014 Jun). NGC:010475
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
The management of women with red cell antibodies during pregnancy. 2014 May. NGC:010419
Royal College of Obstetricians and Gynaecologists - Medical Specialty Society. View all guidelines by the developer(s)
6.  
Evaluation and treatment of cryptorchidism: AUA guideline. 2014 Apr. NGC:010424
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)
7.  
Management of beta thalassaemia in pregnancy. 2014 Mar. NGC:010322
Royal College of Obstetricians and Gynaecologists - Medical Specialty Society. View all guidelines by the developer(s)
8.  
BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. 1999 (revised 2014 Feb). NGC:010300
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
9.  
10.  
11.  
ACR Appropriateness Criteria® dementia and movement disorders. 1996 (revised 2014). NGC:010450
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
12.  
Blood transfusion in the management of sickle cell disease. In: Evidence-based management of sickle cell disease. 2014. NGC:010534
National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
13.  
Health maintenance for people with sickle cell disease. In: Evidence-based management of sickle cell disease. 2014. NGC:010530
National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
14.  
Hydroxyurea therapy in the management of sickle cell disease. In: Evidence-based management of sickle cell disease. 2014. NGC:010533
National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
15.  
Managing acute complications of sickle cell disease. In: Evidence-based management of sickle cell disease. 2014. NGC:010531
National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
16.  
Managing chronic complications of sickle cell disease. In: Evidence-based management of sickle cell disease. 2014. NGC:010532
National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
17.  
Practice parameter for the assessment and treatment of children and adolescents with tic disorders. 2013 Dec. NGC:010493
American Academy of Child and Adolescent Psychiatry - Medical Specialty Society. View all guidelines by the developer(s)
18.  
Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors. 2002 Apr (revised 2013 Oct). NGC:010320
National Society of Genetic Counselors - Medical Specialty Society. View all guidelines by the developer(s)
19.  
Investigation and management of non-immune fetal hydrops. 2013 Oct. NGC:010094
Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society. View all guidelines by the developer(s)
20.  
Inherited thrombophilias in pregnancy. 2010 Apr (revised 2013 Sep). NGC:009990
American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s)
1-20 of 242   Next >